The present invention is directed to new crystalline forms of Atorvastatin calcium (2:1), referred to hereinafter as polymorphic Forms X, A, B1, B2, C, D and E. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.

 
Web www.patentalert.com

< Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds

> Sugar derivatives comprising oxiranes or .alpha., .beta.-unsaturated .gamma.-lactones, process for their preparation and their utilisation as pesticides

> Methods for purifying carbon materials
~ 00521